Cargando…
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
The histiocytoses are rare tumors characterized by the primary accumulation and tissue infiltration of histiocytes and dendritic cells. Identification of the activating BRAFV600E mutation in Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) cases provided the basis for the treatm...
Autores principales: | Gatalica, Zoran, Bilalovic, Nurija, Palazzo, Juan P., Bender, Ryan P., Swensen, Jeffrey, Millis, Sherri Z., Vranic, Semir, Von Hoff, Daniel, Arceci, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637323/ https://www.ncbi.nlm.nih.gov/pubmed/26110571 |
Ejemplares similares
-
PD-L1 Status in Refractory Lymphomas
por: Vranic, Semir, et al.
Publicado: (2016) -
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases
por: Gatalica, Zoran, et al.
Publicado: (2014) -
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
por: Joneja, Upasana, et al.
Publicado: (2017) -
Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature
por: Vranic, Semir, et al.
Publicado: (2008) -
Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast
por: Vranic, Semir, et al.
Publicado: (2018)